![[img]](https://epub.uni-regensburg.de/style/images/fileicons/application_pdf.png) | Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (3MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-538974
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.53897
Carnell, George W. ; Billmeier, Martina ; Vishwanath, Sneha ; Suau Sans, Maria ; Wein, Hannah ; George, Charlotte L. ; Neckermann, Patrick ; Del Rosario, Joanne Marie M. ; Sampson, Alexander T. ; Einhauser, Sebastian 
; Aguinam, Ernest T. ; Ferrari, Matteo ; Tonks, Paul ; Nadesalingam, Angalee ; Schütz, Anja ; Huang, Chloe Qingzhou ; Wells, David A. ; Paloniemi, Minna ; Jordan, Ingo ; Cantoni, Diego ; Peterhoff, David ; Asbach, Benedikt ; Sandig, Volker ; Temperton, Nigel ; Kinsley, Rebecca ; Wagner, Ralf ; Heeney, Jonathan L.
; Aguinam, Ernest T. ; Ferrari, Matteo ; Tonks, Paul ; Nadesalingam, Angalee ; Schütz, Anja ; Huang, Chloe Qingzhou ; Wells, David A. ; Paloniemi, Minna ; Jordan, Ingo ; Cantoni, Diego ; Peterhoff, David ; Asbach, Benedikt ; Sandig, Volker ; Temperton, Nigel ; Kinsley, Rebecca ; Wagner, Ralf ; Heeney, Jonathan L. Zusammenfassung
The accelerated development of the first generation COVID-19 vaccines has saved millions of lives, and potentially more from the long-term sequelae of SARS-CoV-2 infection. The most successful vaccine candidates have used the full-length SARS-CoV-2 spike protein as an immunogen. As expected of RNA viruses, new variants have evolved and quickly replaced the original wild-type SARS-CoV-2, leading ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik